Published in Women's Health Weekly, June 8th, 2000
The drug, Fareston, marketed by Kentucky-based Shire Roberts under the generic name toremifene, is in the same class as tamoxifen.
A trial of 899 patients showed the two drugs worked about equally in women past menopause who had undergone surgery for the same stage of breast cancer. The patients were followed for a little over three years on average.
"The results of this study are of significant importance because they show that Fareston is as effective as tamoxifen in the adjuvant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly